COPZ2 and central nervous system cancer: Thus, to test whether COPZ2-driven malignant behaviors in glioma cells through PI3K − AKT signaling pathways, rescue experiments were conducted by treating U251 and U87 cells with SC79 (PI3K − AKT signaling pathways activator).